Online
| Post a Message | Explore Forums | Browse Stock Messages | Hot Discussions | Top rated Messages | Top Boarders | |
|
|
|
Cipla
Cipla looks excellent
Posted by :
basit222Tracked by: 1 Boarder
Technical Analyst, Ashwani Gujral is of the view that Cipla looks excellent to go upto Rs 270-275...
Cipla behaves inversly to the sensex
Posted by :
GuestTracked by: 0 Boarder
It doesn\\`t mean anything. Treat the company like a business and understand it. Invest in it at the right price for value obtained....
In reply to:
Cipla behaves inversly to the sensex
Posted by :
prasadrn
Hi, I have noticed a fact that Cipla\\\'s behavious is inversly proportional to the sensex. Can anyone explain the rationale of this behavior. 
target 275
Posted by : basit222Tracked by: 0 Boarder
buy cipla for short term target 275/...
buy back
Posted by : basit222Tracked by: 0 Boarder
any news for buy back...
Tracked by: 0 Boarder
If ur not in urgent need of money, i would suggest you to wait for atleast another 3 months. I am sure it will cross you buy prices. don't sell in loss. ...
In reply to:
CIPLA
Posted by : meet1234
I HAVE 100 SHARES CIPLA FOR THE RATE OF255 SHALL I HOLD OR SELL
Will Cipla Reach To 240 Levels?
Posted by : JuggyDTracked by: 0 Boarder
Will Cipla Reach To 240 Levels in Near Future say 4-5 days?...
NSE Announcements on Cipla
Posted by : MMB MessengerTracked by: 0 Boarder
Cipla Ltd. has informed the Exchange that dividend warrants for the year 2007-2008 will be dated on or about September 04, 2008 and will be dispatched to the shareholders within the stipulated time limit....
Cipla behaves inversly to the sensex
Posted by : prasadrnTracked by: 0 Boarder
Hi, I have noticed a fact that Cipla\\\'s behavious is inversly proportional to the sensex. Can anyone explain the rationale of this behavior....
Clinton Foundation buys AIDS drug from CIPLA
Posted by : zoombusinessTracked by: 0 Boarder
The Bill Clinton Foundation has bought huge quantities of paediatric antiretroviral formulations from Mumbai-based Cipla for distribution in 62 developing countries in Africa, Asia, Latin America and the Caribbean.
Together, these countries represent more than 90% of children living with HIV/AIDS in developing countries. Some 4.3 million children under 15 have died worldwide as a result of AIDS.
Last year, over six lakh children were newly-infected with HIV, and more than 1,600 are infected every day, according to recent estimates. Confirming the development, Amar Lulla, Cipla\'s joint MD, said, \"Since we are the only firm to have developed a paediatric dosage form of the AIDS drug, the Clinton Foundation has taken advantage of the generic version and included it in its distribution network.\"
Children are an afterthought when it comes to producing appropriate formulations of medicines. Of the 22 anti retrovirals approved by the US Food and Drug Administration till last year, eight are not approved for use in children and nine are not available in paediatric formulation.
Cipla\'s child-friendly drug is a three-in-one tablet that replaces individual solutions, for less than $60 per year, or 16 cents per day, per child. Given that many current AIDS drugs are made only in dosages and formats appropriate for adults, the new generic drug has been made specifically for easy administration to children.
The drug needs no refrigeration, which is an advantage in underdeveloped countries lacking electricity, and can
be split in half and dissolved fully in water, making it suitable for use even in children too young to swallow pills. The dosing depends on the child\'s weight.
-TOI-...
technical analyst
Posted by :
GunaTracked by: 0 Boarder
yes, these stocks are moving above 200 dma, along with phama sector....
In reply to:
technical analyst
Posted by : basit222
In the pharma space, Cipla, Sun Pharma and Lupin look good on the charts and one can look at buying them on declines, says Salil Sharma, technical analyst
unbeleivable target
Posted by : psgsTracked by: 2 Boarders
yes basit222,
cipla is one such bluechip frontline stock which can pull it out.
inspite of earnings downgrade a couple of years back, the stock has been giving 15-20% returns without any breakdown in stock price. thats unbelievable and truly spectacular.
1week 2week 1month 3month 6month 9month 1year
220.05 222.95 211.35 207.80 186.40 182.00 190.90 Price
3.98% 2.62% 8.26% 10.11% 22.75% 25.71% 19.85% Return
isn't that wonderful enough. no negative returns in the past one year
inspite of market crash. its been a truly.
swamy.
...
In reply to:
unbeleivable target
Posted by : basit222
unbeleivable target of 1 year . invest and realx no need of tension life will be great once u invest and reap the hravest after 1 year
technical analyst
Posted by : basit222Tracked by: 0 Boarder
In the pharma space, Cipla, Sun Pharma and Lupin look good on the charts and one can look at buying them on declines, says Salil Sharma, technical analyst...
Rs 255-260
Posted by : basit222Tracked by: 0 Boarder
Once Cipla moves above Rs 220-225, it can go up to Rs 255-260, says Vijay Bhambwani, technical analyst, on CNBC Awaaz. The stock is currently trading at Rs 235.45, up 0.4% on the BSE....
unbeleivable target
Posted by : basit222Tracked by: 2 Boarders
unbeleivable target of 1 year . invest and realx no need of tension life will be great once u invest and reap the hravest after 1 year...
More from the Pharmaceuticals Sector
Boarders tracking Cipla
see more News Updates on Cipla
